ALLR
ALLR
NASDAQ · Biotechnology

Allarity Therapeutics Inc

$1.55
+0.05 (+3.33%)
As of May 16, 2:28 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +2,001.9% upside
Low Target $17.80
Average Target $32.58
High Target $40.39
Current Price $1.55
Current
$1.55
Target
$32.58
$17.80 $32.58 avg $40.39
Scenario Analysis
Bear Case
$17.80
1,048.4%
Low target
Base Case
$32.58
+2,001.9%
Avg target
Bull Case
$40.39
+2,505.8%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$2.35
-34.0% from high
52-Week Low
$0.77
+101.6% from low
Target vs 52W High
$32.58
+1,286.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.6%